Recent drop in post-discharge mortality after acute MI

October 16, 2012
Recent drop in post-discharge mortality after acute MI
For patients with acute myocardial infarction, post-discharge mortality rates decreased from 2001 to 2007, according to a study published in the Oct. 15 issue of The American Journal of Cardiology.

(HealthDay)—For patients with acute myocardial infarction (AMI), post-discharge mortality rates decreased from 2001 to 2007, according to a study published in the Oct. 15 issue of The American Journal of Cardiology.

Andrew H. Coles, Ph.D., of the University of Massachusetts Medical School in Worcester, and colleagues conducted a population-based study of 2,452 patients (mainly older, male, and white) treated for initial AMI at 11 central Massachusetts medical centers in 2001, 2003, 2005, and 2007. The authors sought to examine factors associated with .

The researchers found that the three-month, one-year, and two-year all-cause mortality rates were 8.9, 16.4, and 23.4 percent, respectively, overall. In crude and multivariate-adjusted analyses, there was a reduction in the post-discharge mortality over time. The rates at three months, one year, and two years were 11.1, 17.1, and 25.6, respectively, in 2001, and decreased to 7.9, 12.7, and 18.6 percent for patients discharged in 2007. An increased risk of death after discharge was associated with older age, male gender, hospitalization for a non-ST-segment elevation AMI, renal dysfunction, and preexisting heart failure.

"These results suggest that the post-discharge prognosis of patients with initial AMIs has improved, likely reflecting enhanced in-hospital and post-discharge management practices," the authors write. "Patients with initial AMIs can also be identified who are at increased risk for dying after hospital discharge, in whom increased surveillance and targeted treatment approaches can be directed."

Explore further: Post-radical cystectomy discharge patterns described

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

Post-radical cystectomy discharge patterns described

March 29, 2012
(HealthDay) -- In the past decade there has been a decrease in prolonged length of stay following radical cystectomy in the United States, while rates of transfer to a facility have remained stable, with insurance status ...

What do patients receiving optimal medical therapy after a heart attack die from?

August 30, 2011
Because of improved management at the acute stage, the risk of dying in hospital after a heart attack has decreased by about 50% in the past 10 years. Likewise, the prescription of recommended medications when patients leave ...

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.